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Loss of Chromosome Y in Prostatic Cancer Cells, 
but not in Stromal Tissue 
Loss of the Y Chromosome has been seen in a variety of hu- 
man neoplasms [1]. Whether it has diagnostic or prognostic 
significance is at present not clear. The loss of this chromo- 
some has been detected by means of metaphase t chniques, 
for which culturing is needed, and by in situ hybridization 
[ISH) to interphase preparations [1], and, e.g., 2]. 
In a recent paper in this journal, loss of the Y chromo- 
some was described in tissue cultures of gastric ancer cells 
by Castedo et al. [3]. This was compared with interphase ISH 
results in another study [2]. The suggestion was made that 
the Y-deficient cells were of stromal, and not of neoplastic 
origin. It was hypothesized that stromal cells without the 
Y chromosome could comply better with cancerous growth 
requirements. The authors pointed out that ISH to gastric 
tumor tissue sections could reveal significant data in this re- 
spect. 
We have been using interphase ISH to routinely process 
tissue sections of solid tumors for the numerical analysis of 
specific chromosomes [4]. Recently, aprostatic adenocarci- 
noma was seen with loss of chromosome Y in neoplastic cells, 
but not in the stromal cells {fibroblasts, endothelium, leu- 
kocytes, nerve cell nuclei, etc.}. Also, hyperplastic and nor- 
mal prostatic epithelium contained a chromosome Y-related 
ISH signal. In Figure 1, a part of this tumor is shown {Glea- 
son Grade 2 area). The differences between the Y-bearing 
stmmal cells and the Y-lacking cancer cell nuclei is obvious. 
Our conclusion is that loss of chromosome Y in stromal 
tissue components was not required for these cells to prolifer- 
ate with the neoplastic ells in this prostate tumor. Further, 
Y-loss was restricted to the cancer cells. This sheds ome light 
on cytogenetic findings of cancer cell cultures and ISH results 
of tumor cell suspensions [2, 3]. It might be that the above- 
described phenomenon could vary in malignancies ofdiffer- 
ent histologies. However, the investigation of issues of this 
{and other} nature can very well be addressed by interphase 
in situ hybridization of histologic sections. 
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Figure 1 In situ hybridization with the chromosome Y-specific alpha-satellite DNA probe to a 4-~m section f a 
prostatic adanocarcinoma. The ISH spots were visualized with immunopemxidase/DAB (black); hemataxylin was 
used as a counterstain (grey). Y chromosome-related signals can be seen in the stromal cell nuclei (some are arrowed), 
but not in the prostatic glands (marked G; 40 x objective). Control hybridizations with autosomal lphoid DNA probes 
revealed signals in stromal and prostatic tumor cell types. 
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